These results reveal the linkage between CIB1, reprogrammed glucose metabolism, and the KRAS pathway, as well as the relevance of CIB1 expression to tumor and stromal cellular components and immune cell modulation in the TME. The gene discussed is KRAS; the disease is neoplasm.